Universal Ibogaine Inc. (IBOGF)
OTCMKTS · Delayed Price · Currency is USD
0.0120
+0.0055 (84.62%)
Feb 12, 2026, 1:43 PM EST
Universal Ibogaine Revenue
Universal Ibogaine had revenue of 700.92K CAD in the quarter ending April 30, 2025, with 30.61% growth. This brings the company's revenue in the last twelve months to 2.06M, down -11.68% year-over-year. In the fiscal year ending July 31, 2024, Universal Ibogaine had annual revenue of 2.33M with 126.32% growth.
Revenue (ttm)
2.06M CAD
Revenue Growth
-11.68%
P/S Ratio
0.77
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.14M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2024 | 2.33M | 1.30M | 126.32% |
| Jul 31, 2023 | 1.03M | -40.82K | -3.81% |
| Jul 31, 2022 | 1.07M | - | - |
| Jul 31, 2021 | - | - | - |
| Jul 31, 2020 | - | - | - |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evofem Biosciences | 17.73M |
| Emmaus Life Sciences | 11.89M |
| EV Biologics | 9.47M |
| International Stem Cell | 9.39M |
| Lipella Pharmaceuticals | 389.78K |
| Halberd | 6.94K |
Universal Ibogaine News
- 24 days ago - Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process - TheNewswire
- 5 weeks ago - Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process - TheNewswire
- 2 months ago - Universal Ibogaine Provides Bi-weekly Default Status Report on 2025 Year-end Filings and Update on Restructuring Process - TheNewswire
- 2 months ago - Universal Ibogaine advises further on application for Management Cease Trade Order - TheNewswire
- 2 months ago - Universal Ibogaine Advises of Filing Application for Management Cease Trade Order - TheNewswire
- 3 months ago - Universal Ibogaine Provides Corporate Update - TheNewswire
- 5 months ago - Universal Ibogaine Announces Board Changes - TheNewswire
- 5 months ago - Universal Ibogaine Announces Results of the Annual Meeting of Shareholders - TheNewswire